STOCK TITAN

PBYI (NASDAQ: PBYI) holder files Rule 144 to sell shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a Rule 144 notice to sell 6,405 shares of common stock of the issuer through Fidelity Brokerage Services LLC on 01/07/2026, with an aggregate market value of $37,655.00. The filing notes that there are 50,391,107 shares of this common stock outstanding and that the shares to be sold were acquired on 01/02/2026 via restricted stock vesting as compensation from the issuer. Over the prior three months, the same seller, Maximo Nougues, sold 4,540 common shares for gross proceeds of $26,529.94. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PBYI shares are planned to be sold under this Rule 144 notice?

The notice covers a proposed sale of 6,405 shares of common stock of the issuer under Rule 144.

What is the aggregate market value of the PBYI shares to be sold?

The 6,405 common shares to be sold have an aggregate market value of $37,655.00 as stated in the filing.

How and when were the securities in this PBYI Rule 144 filing acquired?

The common shares were acquired on 01/02/2026 through restricted stock vesting from the issuer as compensation.

How many PBYI shares has the seller disposed of in the past three months?

Over the past three months, Maximo Nougues sold 4,540 common shares for $26,529.94 in gross proceeds.

How many PBYI common shares are reported as outstanding in this notice?

The Rule 144 notice reports that there are 50,391,107 shares of the issuer’s common stock outstanding.

Which broker and exchange are involved in this PBYI Rule 144 sale?

The proposed sale is through Fidelity Brokerage Services LLC, and the common stock is listed on the NASDAQ exchange.

What representation does the seller make about inside information in this PBYI filing?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Puma Biotechnology Inc

NASDAQ:PBYI

PBYI Rankings

PBYI Latest News

PBYI Latest SEC Filings

PBYI Stock Data

320.99M
42.77M
15.43%
68.25%
5.49%
Biotechnology
Pharmaceutical Preparations
Link
United States
LOS ANGELES